Moteur de recherche d’entreprises européennes

Financement de l’UE (20 M €) : Implants intelligents pour l’enrichissement de la vie Hor16/12/2024 Programme de recherche et d'innovation de l'UE « Horizon »

Vue d’ensemble

Texte

Implants intelligents pour l’enrichissement de la vie

Non-Communicable Diseases (NCDs) e.g. osteoporosis, osteoarthritis, joint & ligament wear, frailty fractures and associated complications in elderly are a severe threat frequently leading to a permanent decline of the patient’s general health and autonomy. NCD prevention is highly relevant to reduce the need for long-term care. The economic burden is expected to increase by 65% from 2020 to 2040 with a strong negative impact on patient’s quality of life. SmILE will provide a cross-sectoral, early risk detection methodology by holistic analysis of elderly patients’ health data. Co-creation with end-users and consideration of diverse needs, mental and physical abilities, living and socio-economic conditions as well as life-situation of older people are implemented. This includes training and enhanced stream of information to patients and other stakeholders. It will offer an AI-based patient analysis, incl. integration of smart wearables and medical devices incl. implants to support monitoring of general health status. Our approach will disrupt the cycle of frailty by minimizing physical decline and risk of re-fractures. To enhance the AI functions, new data sources will be established by instrumenting medical devices, mainly implants, to augment them into monitoring and actively supporting devices. SMILE will: (1) develop an integrated platform to collect, centralize, manage, analyze and share multimorbid geriatric patient data using technology such as AI & machine learning; (2) establish a pan-European bottom-up model of good governance of health data being patient-centered and patient-controlled in line with current regulations; and (3) establish a solution driven by the needs of citizens and patients of old age. SMILE will establish a new approach of outcome-monitoring to provide patient centered, personalized and integrated treatment of elderly NCD patients to improve quality of life, enable real empowerment and ease the financial burden in an ageing society.


Csem Centre Suisse D'Electronique ET DE Microtechnique SA - Recherche ET Developpement ?
Aesculap AG 381 250 €
Associação Fraunhofer Portugal Research 1 955 865 €
Betthera s.r.o. 383 750 €
BG Klinikum Hamburg gGmbH 1 024 084 €
Bosch Sensortec GmbH 1 052 647 €
Consorcio Centro de Investigacion Biomedica en Red M.P 400 569 €
Eurice European Research AND Project Office GmbH 700 312 €
Fraunhofer Gesellschaft ZUR Forderung DER Angewandten Forschung e. V. 1 686 473 €
Fundacio Eurecat 729 875 €
Fundacion Centro de Cirugia de Minima Invasion Jesus Uson 338 781 €
Innoproof GmbH 125 065 €
Interuniversitair Micro-Electronica Centrum 1 396 020 €
Luxembourg Institute OF Health 1 592 613 €
Minds & Sparks GmbH 385 000 €
Oncare GmbH 1 246 250 €
Research AND Innovation Services d.o.o. 0,00 €
Robert Bosch AB 0,00 €
Swemac Innovation (Germany) GmbH 0,00 €
Swemac Innovation AB 686 625 €
Universita Degli Studi Di Brescia 478 314 €
Universitaet Rostock 421 153 €
Universitaet zu Luebeck 0,00 €
Universitat DES Saarlandes 554 125 €
Universitatsklinikum Schleswig-Holstein 3 174 780 €
Universitatsmedizin Rostock 523 509 €
Zema - Zentrum FUR Mechatronik Undautomatisierungstechnik Gemeinnutzige GmbH 755 125 €

https://cordis.europa.eu/project/id/101136376

Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel. L’état actuel est présenté à la page suivante : CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Développement, Neuchâtel, Suisse.